Trial Profile
Efficacity and Safety of Metformin XR in CKD Stage 1 to 3
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2023
Price :
$35
*
At a glance
- Drugs Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms METXR/CKD
- 09 May 2023 Status changed from recruiting to completed.
- 03 Oct 2018 Planned End Date changed from 1 Sep 2017 to 30 Aug 2020.
- 03 Oct 2018 Planned primary completion date changed from 1 Sep 2017 to 30 Aug 2020.